Ostrowski

TL2 Member · Vilnius, LT

Practical questions, practical answers. Not interested in speculation without a source.

Joined 6 January 2025 · last posted 5d · groups: regional-na, regional-apac

75 posts, newest first. Showing up to 150.

What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #15 · Compounds › Tirzepatide · 23 Jul 2026 · 9 likes Building on post #14 rather than restating it. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with…
Insurance and replacement policies, compared Replied, post #83 · Sourcing › Logistics · 12 Jul 2026 · 1 like Building on post #82 rather than restating it. Source for the insurance and replacement policies figure, since it was asked for. It is in the discussion rather than the…
Private prescribing in the UK: what is actually involved Replied, post #60 · Regional › UK & Ireland · 9 Jul 2026 · 6 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
Seven-day rolling means and why weekly readings mislead Replied, post #2 · Outcomes › Progress reports · 8 Jul 2026 · 0 likes Worth separating seven-day rolling as a question about the compound from seven-day rolling as a question about the documentation. They get answered by different people…
Follow-up: Signs of dehydration worth acting on Replied, post #16 · Safety › Adverse events · 7 Jul 2026 · 0 likes My experience of Signs of dehydration worth acting contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's…
Tracking a shortage from primary sources rather than rumour Replied, post #86 · Access › Shortages · 5 Jul 2026 · 0 likes Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.
Revisiting: Protein density versus volume when you cannot eat much Replied, post #20 · Nutrition & Training › Protein & intake · 30 Jun 2026 · 4 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #10 · Nutrition & Training › Protein & intake · 26 Jun 2026 · 1 like Post #9 answers the question as asked. The question underneath it is different. Reading back through the Protein density versus volume threads from last year, the same…
Documenting a supplier's response to a discrepancy Replied, post #8 · Sourcing › Vendor reports · 4 Jun 2026 · 8 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #9 · Evidence › Journal club · 31 May 2026 · 8 likes I would be cautious about generalising from the SURMOUNT-OSA example above. It is a good example. It is one example.
Coming back to: A structured critique template this community uses Replied, post #19 · Evidence › Study critique · 26 May 2026 · 8 likes On structured critique template, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range…
What a good consultation looks like from the other side Replied, post #37 · Clinical › Prescriber conversations · 3 May 2026 · 29 likes That reframing is the whole thing. The facts I already had.
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #15 · Compounds › Retatrutide · 16 Apr 2026 · 0 likes Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious plateau within it. Extrapolating beyond the highest studied dose from that…
Spike-and-recover accuracy for a peptide assay Replied, post #17 · Analytics › Method validation · 7 Apr 2026 · 3 likes Adding a null result on spike-and-recover accuracy. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #121 · Pharmacology › Pharmacokinetics · 1 Apr 2026 · 8 likes Building on post #120 rather than restating it. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is…
Reused chromatograms across lots: how to spot it Replied, post #28 · Analytics › COA interpretation · 21 Mar 2026 · 0 likes Reading this reused chromatograms across lots thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Pregnancy and pregnancy planning: contraindication and washout Replied, post #73 · Clinical › Special populations · 14 Mar 2026 · 5 likes Adding a null result on pregnancy and pregnancy planning. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #143 · Analytics › COA interpretation · 2 Mar 2026 · 0 likes This follows post #140 rather than contradicting it. Asking for the batch record rather than the certificate is a reasonable request and the response to it is…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #112 · Practice › Interactions · 15 Feb 2026 · 2 likes The arithmetic on Warfarin and altered intake is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #35 · Pharmacology › Pharmacokinetics · 7 Feb 2026 · 23 likes The most useful thing anyone has posted about Washout in this category was a table of what had been measured and by whom. That is what I would want again.
Non-inferiority margins: how they are chosen and how they are abused Replied, post #43 · Evidence › Trials · 5 Feb 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #3 · Clinical › Special populations · 20 Jan 2026 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Pregnancy and pregnancy planning looks different depending on whether you…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #11 · Evidence › Trials · 20 Jan 2026 · 0 likes Picking up post #8: that is the part I would want checked first. Non-inferiority margins are chosen, and the choice is an argument rather than a fact. A wide margin can…
Cost per delivered dose, which is the number that matters Replied, post #39 · Access › Pricing · 15 Jan 2026 · 31 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live. Somebody will…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #64 · Clinical › Special populations · 30 Dec 2025 · 8 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit. I would…
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 26 Dec 2025 · 1 like Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #14 · Access › International · 16 Dec 2025 · 0 likes This follows post #13 rather than contradicting it. Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first…
Publishing an inconvenient result: a case study — the long version Replied, post #59 · Sourcing › Independent verification · 4 Dec 2025 · 25 likes Post #58 is right about the mechanism and I think understates the practical bit. Asking the supplier before publishing a discrepancy is the convention here. Most…
The headache that turns out to be dehydration Replied, post #78 · Nutrition & Training › Hydration & electrolytes · 1 Dec 2025 · 3 likes Coming back to post #74, because the follow-up matters more than the original answer. An observation about headache that I cannot explain and am posting anyway, on the…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #47 · Compounds › Oral incretins · 16 Nov 2025 · 0 likes Everything in post #44 holds. The case it does not cover is the one I have. The thirty-minute wait before eating is not conservatism. Food in the stomach materially…
Documentation that materially improves an appeal's chances Replied, post #61 · Access › Insurance & coverage · 12 Nov 2025 · 28 likes Where a criterion requires documented prior attempts, the documentation has to exist in the record rather than in your memory of it.
The anatomy of a question that gets answered within an hour — the long version Replied, post #74 · Start Here › How to Ask · 8 Nov 2025 · 3 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it.
Managing an unplanned gap in supply — what changed since Replied, post #88 · Access › Shortages · 15 Oct 2025 · 23 likes Coming back to post #84, because the follow-up matters more than the original answer. Reading back through the Managing an unplanned gap threads from last year, the…
Thyroid function tests during substantial weight change Replied, post #96 · Clinical › Bloodwork · 15 Oct 2025 · 4 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. I would rather post the uncertainty than round it away.
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #6 · Practice › Side effects · 7 Oct 2025 · 13 likes I think the Dizziness on standing question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Where impurities in solid-phase peptide synthesis come from Replied, post #11 · Analytics › Impurities & related substances · 3 Oct 2025 · 0 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #22 · Analytics › Method validation · 19 Sep 2025 · 1 like Seconded. It reads as careful rather than confident, which is the right register.
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #49 · Compounds › Secretagogues & GH axis · 18 Sep 2025 · 8 likes Post #48 is the version of this I will quote in future. One addition. Reading a rodent study was covered in the wiki last year and the page has a review date on it,…
Power cut for eleven hours: how I assessed it afterwards Replied, post #60 · Practice › Storage & stability · 17 Sep 2025 · 23 likes Fair, and the limits you put on it are the part I will remember.
Sleep quality changes during weight loss — what changed since Replied, post #2 · Wellbeing › Sleep · 16 Sep 2025 · 15 likes Sleep quality changes reported here have several plausible contributors, and separating drug effects from weight change, from schedule change, and from anxiety is…
What this community means by "a source", in practical terms Replied, post #110 · Start Here › Welcome · 12 Sep 2025 · 5 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #104 · Data & Tools › Datasets · 10 Sep 2025 · 18 likes The most useful reply I ever got about Aggregated purity results across four was a request to state my units. It sounds like pedantry and it has saved me twice.
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #61 · Analytics › HPLC & UHPLC · 7 Sep 2025 · 0 likes Small correction to my own earlier position on Resolution and tailing factor. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
What I would record differently if I started again — the long version Replied, post #9 · marked as the solution · Outcomes › Progress reports · 5 Sep 2025 · 7 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #75 · Evidence › Journal club · 4 Sep 2025 · 1 like People arriving without having read it should be welcome and should say so, because a question from someone who has not read it frequently exposes an assumption…
A ten-fold dose error caught before injection Replied, post #72 · Devices › Syringes & needles · 28 Jul 2025 · 0 likes Everything in post #69 holds. The case it does not cover is the one I have. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are…
Coming back to: What published stability data actually covers, and what it does not Replied, post #93 · Practice › Storage & stability · 22 Jul 2025 · 0 likes Two things can be true about published stability data actually covers at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of…
Revisiting: Food effects on oral incretin absorption: what is documented Replied, post #11 · Compounds › Oral incretins · 9 Jul 2025 · 5 likes The arithmetic in post #8 is right; the assumption feeding it is the part to check. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg…
Coming back to: What happens when a maintainer goes quiet Replied, post #4 · Documentation › Doc review · 5 Jul 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #20 · Analytics › HPLC & UHPLC · 25 Jun 2025 · 2 likes The version of Area percent versus weight percent that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Random versus fixed effects: choosing rather than defaulting Replied, post #6 · Evidence › Meta-analyses · 18 Jun 2025 · 0 likes Taking post #3 at face value and following it one step further. Where the pooled result and the largest single trial disagree, that disagreement is the interesting…
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #14 · Clinical › Bloodwork · 13 Jun 2025 · 13 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Follow-up: Tracking intake honestly when appetite is absent Replied, post #41 · Nutrition & Training › Protein & intake · 8 Jun 2025 · 6 likes Where I part company with post #39, and it is a narrow parting. Density matters more than quantity when total intake is limited. The same protein in a smaller volume is…
Second pass at: Designing a personal experiment that could change your mind Replied, post #39 · Research Methods › N-of-1 designs · 21 May 2025 · 30 likes Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary. Not the answer, but…
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #23 · Practice › Administration · 29 Apr 2025 · 11 likes Confirming post #22 from a second method, which matters more than confirming it from a second person. Cold solution and stinging: warming the vial in your hands for a…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #100 · Evidence › Journal club · 21 Apr 2025 · 25 likes Worth separating STEP 1 as a question about the compound from STEP 1 as a question about the documentation. They get answered by different people and only one of them…
Fibre intake when total intake falls, and the constipation link Replied, post #55 · Nutrition & Training › Protein & intake · 18 Apr 2025 · 2 likes Distribution across the day appears to matter less than total for most outcomes, and it matters practically because a single large meal is harder when appetite is…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #26 · Sourcing › Vendor reports · 15 Mar 2025 · 0 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #63 · Compounds › Semaglutide · 14 Feb 2025 · 11 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #21 · Compounds › Other compounds · 12 Feb 2025 · 10 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
Attributing a new peak: degradation product or excipient? Replied, post #2 · marked as the solution · Analytics › Impurities & related substances · 27 Jan 2025 · 8 likes Storage-related degradation and synthesis-related impurity look different on a chromatogram. A growing oxidation peak over time is not a manufacturing finding.
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #8 · Access › International · 21 Jan 2025 · 30 likes On post #6 — agreed on the reasoning, with one qualification. I read the earlier replies on Cross-border purchase within twice before writing this, because I had…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #25 · Evidence › Journal club · 16 Jan 2025 · 2 likes On STEP 4: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #30 · Compounds › Oral incretins · 8 Jan 2025 · 26 likes Post #28 is the version of this I will quote in future. One addition. The absorption enhancer in the licensed oral product works by transiently raising local gastric pH…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #7 · Practice › Reconstitution · 3 Jan 2025 · 15 likes Adding the measurement that post #5 says would settle it. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common…
Coming back to: When to suspect the method rather than the sample Replied, post #87 · Analytics › Method validation · 17 Dec 2024 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
A promotion I argued against, and why I lost Replied, post #17 · Documentation › Doc review · 30 Nov 2024 · 17 likes Post #14 put the caveat in the right place and I want to underline it. A promotion that is declined should leave the topic linked from wherever the question recurs, so…
Follow-up: Recovery when intake is low: what to cut first Replied, post #23 · Nutrition & Training › Resistance training · 14 Nov 2024 · 1 like Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #35 · Wellbeing › Mental health · 17 Oct 2024 · 3 likes Understood, and I withdraw the assumption I opened with.
Blind submission and why it changes minds Replied, post #69 · Sourcing › Independent verification · 24 Sep 2024 · 0 likes Where I part company with post #67, and it is a narrow parting. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
Progressive overload when the scale is falling — one year on Replied, post #6 · Nutrition & Training › Resistance training · 26 Aug 2024 · 10 likes The reason Progressive overload is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
Request: a diff view for wiki revisions Replied, post #7 · Meta › Feature requests · 24 Aug 2024 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #12 · Sourcing › Independent verification · 23 Aug 2024 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
The C-cell question: rodent findings and their human context — what changed since Replied, post #11 · Compounds › Semaglutide · 17 Aug 2024 · 16 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Pancreatitis history and the risk calculus — a second dataset Replied, post #2 · Safety › Contraindications · 11 Jul 2024 · 9 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…